(To see other currencies, click on price)
MORE ABOUT THIS BOOK
Main description:
In Bladder Cancer: Moving the Field Forward, Cheryl Lee, David Wood, and a panel of leading authorities and researchers provide a comprehensive review of the related literature, while providing insights into the obstacles of improved survival and discuss methods to advance the field of Bladder Cancer care. Their work aims to spur innovative thoughts and approaches to common problems in the management of early stage and advanced disease. The book discusses at length the state of bladder cancer staging and the optimal treatment for localized disease. Additional sections review the applications of existing systemic therapies and look at the infrastructure needed to support translational research efforts. Groundbreaking and authoritative, Bladder Cancer: Moving the Field Forward, is the definitive text on the current state of bladder cancer care and a must have for all urologists and medical oncologists who wish to provide their patients with the most comprehensive care.
Contents:
Part I. Improving Bladder Cancer Staging
Section 1. CIS
Chapter 1. Approach to CIS
J. Stephen Jones, MD
Chapter 2. Fluorescent Cystoscopy
H. Barton Grossman, MD
Section 2. Understaging
Chapter 3. Restaging TURBT
Jeffrey Holzberlein, MD
Chapter 4. Understaging T2: Limitations of Pelvic Imaging
Richard Cohan, MD
Chapter 5. MRI Endorectal Coil
Saroja Adusumilli, MD
Chapter 6. PET Imaging: Advances in the Detection of Locally Advanced and Nodal Disease
Morand Piert, MD
Chapter 7. Detection of Extravesical Disease: A Lack of Bladder Cancer Markers
Sam S. Chang, MD
Chapter 8. Identification of Nodal Metastases: The Role of Iron Oxide Enhanced MRI
Bernard Bochner, MD
Chapter 9. Presence and Significance of Micrometastases
Douglas Scher, MD
Part II. Optimizing Treatment of Localized Disease
Section 1: Intravesical Therapy
Chapter 10. Peri-operative intravesical therapy
Ed Messing, MD
Chapter 11. BCG Refractory Disease
Graham Greene, MD
Chapter 12. Beyond BCG: Gemcitabine
Guido Dalbagni, MD
Chapter 13. Beyond BCG: Taxanes
James McKiernan, MD
Section 2: Cystectomy: Cancer Control and Organ Preservation
Chapter 14. Extended Lymph Node Dissection
Marcus Quek, MD
Chapter 15. Prostate Capsule Sparing Cystectomy
Alon Weizer, MD
Chapter 16. Preservation of Reproductive Organs in Women
Gary Steinberg, MD
Chapter 17. Nerve Sparing Cystectomy
Mark Schoenberg, MD
Chapter 18. Quality of Care Indicators for Radical Cystectomy
Badrinath R. Konety, MBBS, MBA
Section 3: Continent Diversion: Problems and Solutions
Chapter 19. Continent Diversion: QOL of Orthotopic Diversion vs Ileal Conduit
Scott Gilbert, MD
Chapter 20. Voiding Dysfunction After Orthotopic Diversion
Jerilyn Latini, MD
Chapter 21. Overcoming the Stigma of Complications of Continent Cutaneous Diversion
Tom Gardner, MD
Part III. Locally Advanced / Distant Disease: Multi-Modality treatment
Chapter 22. Neoadjuvant Chemotherapy: The New Standard
Primo Lara, MD
Chapter 23. Adjuvant Therapy: A Good Concept But Where's the Proof
Timothy Gilligan, MD
Chapter 24. Beyond MVAC: New and Improved Chemotherapeutics
Maha Hussain, MD
Part IV: Next Steps: Translational Research
Chapter 25. The Role of Microarray Technologies in Bladder Cancer Management
Marta Sanchez-Carbayo, PhD
Chapter 26. Development of Novel Agents / Targeted Therapies
Dan Theodorescu, MD
Chapter 27. Tools for Study: National Databanking
Randall Miliken, MD
Chapter 28. Vaccine Development
John Coleman, MD
Chapter 29. Advances in Gene Therapy for Bladder Cancer
Tom Gardner, MD
PRODUCT DETAILS
Publisher: Springer (Humana Press Inc.)
Publication date: March, 2012
Pages: 346
Weight: 735g
Availability: Available
Subcategories: Oncology, Urology
Publisher recommends
From the same series
